Hans Lennart Rudolf Wigzell, Director at Sarepta Therapeutics, Inc. (SRPT), sold 5,000 shares at $116.89 ($584K) on 2020-03-04, disclosed to the SEC on 2020-03-06.
Seasonal sale ($584k) by Director — this insider has traded SRPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| SRPT | SELL | 2023-08-08 | $1.6M | — | Filing → |
| SRPT | SELL | 2021-03-10 | $835K | — | Filing → |
| SRPT | SELL | 2020-08-11 | $3.2M | — | Filing → |